By proceeding, you agree to our Terms of Use and Privacy Policy.
Maarten Kraan is currently working as Chief Medical Officer at AM-Pharma.
Talks About #immunology #clinicaldevelopment
Preferred Locations #Europe
The surge of clinical approvals in CKD and unprecedented use of surrogate endpoints in rare kidney diseases have catalysed a new era of complimentary therapies and precision medicine in drug development for kidney disease.
